Selective enzymatic esterification and solvolysis of epimeric vitamin D analog and separation of the epimers
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TEVA PHARMA IND LTD
- Publication Date
- 2005-07-13
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
field of invention
[0001] The present invention relates to methods for the selective enzymatic esterification and selective enzymatic solvolysis of the C-24 epimer of vitamin D analogues and esters thereof. The present invention further relates to a method of isolating mixed epimers of a vitamin D analog comprising a selective enzymatic esterification step or a selective enzymatic solvolysis step.
[0002] related application
[0003] This application claims priority to US Provisional Patent Application 60 / 348,082, filed January 10, 2002, and US Provisional Patent Application 60 / 349,977, filed January 18, 2002. Background of the invention
[0004] Since its discovery as vitamin D 3 The hormonally active metabolite form of 1α, 25-dihydroxyvitamin D 3 (1,25-(OH) 2 D. 3 ) Since then, many analogues have been prepared in order to obtain active substances with a hypocalcemic effect. Much effort has been devoted to the modification of the vitamin D side chain. While the 1α ...